Literature DB >> 30838096

Stewart Treves Syndrome: A Case Report.

Ali Güleç1, Harun Kütahya2, Nazım Karalezli3, Burkay Kacira3, M Ali Acar4.   

Abstract

Angiosarcomas are malignant tumors, which originate from the vessel endothelium and resemble the vessel structure. Stewart-Treves syndrome is an angiosarcoma which in general, develops in female patients after mastectomy and axillary lymph node dissection and is associated with chronic lymphedema. The prognosis of this rare complication is very poor. We present the case of a 52-year-old female who had undergone mastectomy due to breast cancer and 13 years later required shoulder disarticulation due to Stewart-Treves syndrome.

Entities:  

Keywords:  Angiosarcoma; Lymphedema; Stewart-Treves syndrome

Year:  2014        PMID: 30838096      PMCID: PMC6389662          DOI: 10.5001/omj.2014.38

Source DB:  PubMed          Journal:  Oman Med J        ISSN: 1999-768X


  23 in total

Review 1.  Advanced-technology radiation therapy in the management of bone and soft tissue sarcomas.

Authors:  Thomas F DeLaney; Alexei V Trofimov; Martijn Engelsman; Herman D Suit
Journal:  Cancer Control       Date:  2005 Jan-Feb       Impact factor: 3.302

Review 2.  [Stewart-Treves syndrome].

Authors:  Andrzej L Komorowski; Wojciech M Wysocki; Jerzy Mituś
Journal:  Pol Merkur Lekarski       Date:  2004-05

Review 3.  Angiosarcoma after breast-conserving therapy.

Authors:  Alan T Monroe; Steven J Feigenberg; Nancy Price Mendenhall
Journal:  Cancer       Date:  2003-04-15       Impact factor: 6.860

4.  Radiation-induced angiosarcoma after mastectomy and TRAM flap breast reconstruction.

Authors:  Matthew M Hanasono; Michael P Osborne; Elodi J Dielubanza; Sara B Peters; Lloyd B Gayle
Journal:  Ann Plast Surg       Date:  2005-02       Impact factor: 1.539

Review 5.  Diagnosis, classification, and management of soft tissue sarcomas.

Authors:  Henry J Mankin; Francis J Hornicek
Journal:  Cancer Control       Date:  2005 Jan-Feb       Impact factor: 3.302

6.  Paclitaxel and pegylated-liposomal doxorubicin are both active in angiosarcoma.

Authors:  Keith M Skubitz; Philip A Haddad
Journal:  Cancer       Date:  2005-07-15       Impact factor: 6.860

7.  Radiation dose and risk of soft tissue and bone sarcoma after breast cancer treatment.

Authors:  Carole Rubino; Akthar Shamsaldin; Monique G Lê; Martine Labbé; Jean-Marc Guinebretière; Jean Chavaudra; Florent de Vathaire
Journal:  Breast Cancer Res Treat       Date:  2005-02       Impact factor: 4.872

Review 8.  Lymphedema: an immunologically vulnerable site for development of neoplasms.

Authors:  Vincenzo Ruocco; Robert A Schwartz; Eleonora Ruocco
Journal:  J Am Acad Dermatol       Date:  2002-07       Impact factor: 11.527

Review 9.  Management of angiosarcoma.

Authors:  G Thomas Budd
Journal:  Curr Oncol Rep       Date:  2002-11       Impact factor: 5.075

10.  Antiangiogenetic therapy with pioglitazone, rofecoxib, and metronomic trofosfamide in patients with advanced malignant vascular tumors.

Authors:  Thomas Vogt; Christian Hafner; Klaus Bross; Frauke Bataille; Karl-Walter Jauch; Anna Berand; Michael Landthaler; Reinhard Andreesen; Albrecht Reichle
Journal:  Cancer       Date:  2003-11-15       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.